Pharmacological and molecular characterisation of SK3 channels in the TE671 human medulloblastoma cell line
- 5 April 2002
- journal article
- Published by Elsevier in Brain Research
- Vol. 939 (1-2) , 11-18
- https://doi.org/10.1016/s0006-8993(02)02535-0
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Pharmacological modulation of SK3 channelsNeuropharmacology, 2001
- Apamin interacts with all subtypes of cloned small-conductance Ca 2+ -activated K + channelsPflügers Archiv - European Journal of Physiology, 2001
- Small Conductance Potassium Channels Cause an Activity-Dependent Spike Frequency Adaptation and Make the Transfer Function of Neurons LogarithmicBiophysical Journal, 1999
- Identification of Native Atrial G-protein-regulated Inwardly Rectifying K+ (GIRK4) Channel HomomultimersJournal of Biological Chemistry, 1998
- A human intermediate conductance calcium-activated potassium channelProceedings of the National Academy of Sciences, 1997
- Determinants of Apamin and d-Tubocurarine Block in SK Potassium ChannelsJournal of Biological Chemistry, 1997
- Intrinsic Voltage Dependence and Ca2+ Regulation of mslo Large Conductance Ca-activated K+ ChannelsThe Journal of general physiology, 1997
- Small-Conductance, Calcium-Activated Potassium Channels from Mammalian BrainScience, 1996
- Dequalinium, a selective blocker of the slow afterhyperpolarization in rat sympathetic neurones in cultureEuropean Journal of Pharmacology, 1994
- Dequalinium: a potent inhibitor of apamin-sensitive K+ channels in hepatocytes and of nicotinic responses in skeletal muscleEuropean Journal of Pharmacology, 1993